Filing Details

Accession Number:
0000899243-18-014497
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-30 21:18:13
Reporting Period:
2018-05-25
Accepted Time:
2018-05-30 21:18:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631574 Wave Life Sciences Ltd. WVE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657710 Paul Bolno C/o Wave Life Sciences Ltd.,
733 Concord Ave.
Cambridge MA 02138
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-05-25 8,316 $2.48 287,258 No 4 M Direct
Ordinary Shares Disposition 2018-05-25 8,316 $45.00 278,942 No 4 S Direct
Ordinary Shares Acquisiton 2018-05-29 3,145 $2.48 282,087 No 4 M Direct
Ordinary Shares Disposition 2018-05-29 3,145 $45.00 278,942 No 4 S Direct
Ordinary Shares Acquisiton 2018-05-30 20,250 $2.48 299,192 No 4 M Direct
Ordinary Shares Disposition 2018-05-30 20,250 $45.00 278,942 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Option (right to buy) Disposition 2018-05-25 8,316 $0.00 8,316 $2.48
Ordinary Shares Share Option (right to buy) Disposition 2018-05-29 3,145 $0.00 3,145 $2.48
Ordinary Shares Share Option (right to buy) Disposition 2018-05-30 20,250 $0.00 20,250 $2.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
396,173 2025-03-10 No 4 M Direct
393,028 2025-03-10 No 4 M Direct
372,778 2025-03-10 No 4 M Direct
Footnotes
  1. The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
  2. The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014.